Trial Profile
Repeated Dosing Clinical Trial to Assess the Pharmacokinetic Characteristics and Safety/Tolerability of HL151 Formulation in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary) ; Bepotastine
- Indications Perennial allergic rhinitis
- Focus Pharmacokinetics
- Sponsors Hanlim Pharmaceutical
- 16 Aug 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Feb 2016 New trial record